We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Risk of Recurrence of Depressive Episodes Can Be Predicted by fMRI Scans

By MedImaging International staff writers
Posted on 02 Nov 2015
Print article
A new study shows that Functional Magnetic Resonance Imaging (fMRI) could help predict whether patients risk a recurrence of depressive episodes after recovery from a major depressive disorder.

The study was carried out by researchers from King’s College London (London, UK) and The University of Manchester (Manchester, UK) and was published in the journal JAMA Psychiatry.

In the study the researchers carried out fMRI scans on 64 patients, who were not on prescribed medication, and were in remission from major depressive disorder, to look for atypical connections in the brain. The study participants’ brains were scanned while they experienced guilt or other self-blaming emotions, and were monitored regularly for symptoms over the following 14 months. By the end of the study 27 participants had a recurrence of the depression, while 37 participants remained in remission. Those participants with a recurrence of depression showed a higher level of connection between the anterior temporal lobe and the sub-genual region of the brain, in the fMRI scans. On the other hand those who remained in remission for a year and a control group of 39 people did not have the increased interconnectedness. The results of the study enabled the researchers to accurately predict (75%, 48 out of 64 cases) who would have another depressive episode.

Dr. Kathryn Adcock, head of neurosciences and mental health, MRC, said, “This exciting research has the potential to help identify those individuals who are more likely to suffer from recurrent episodes of depression and will therefore benefit most from long-term treatment and medication. This work could aid the discovery of new treatments for depression because clinical trials will be better able to focus on people with a more comparable disorder and experience.”

Related Links:

King’s College London
University of Manchester 


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Silver Member
Mobile X-Ray Barrier
Lead Acrylic Mobile X-Ray Barriers
New
Breast Imaging Workstation
SecurView
Computed Tomography (CT) Scanner
Aquilion Serve SP

Print article
Radcal

Channels

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

General/Advanced Imaging

view channel
Image: The Tyche machine-learning model could help capture crucial information. (Photo courtesy of 123RF)

New AI Method Captures Uncertainty in Medical Images

In the field of biomedicine, segmentation is the process of annotating pixels from an important structure in medical images, such as organs or cells. Artificial Intelligence (AI) models are utilized to... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.